We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
476
DELISTED
Centessa Pharmaceuticals
CNTA
| $27.9M | 0.03% |
+702,254
| New | +$18M |
|
477
PJT Partners
PJT
$4.36B
| $27.9M | 0.03% |
199,502
+12,412
| +7% | +$1.95M |
|
|
HOLX
478
DELISTED
Hologic
HOLX
| $27.8M | 0.03% |
368,011
-272,172
| -43% | -$20.5M |
|
479
Pan American Silver
PAAS
$18.4B
| $27.8M | 0.03% |
508,746
+248,758
| +96% | +$14.3M |
|
480
CBRE Group
CBRE
$43B
| $27.6M | 0.03% |
204,061
+62,580
| +44% | +$9.51M |
|
481
Frontdoor
FTDR
$5.34B
| $27.5M | 0.03% |
520,752
-123,174
| -19% | -$7.35M |
|
482
DigitalOcean
DOCN
$14.9B
| $27.4M | 0.03% |
318,916
+317,975
| +33,791% | +$20M |
|
483
ESAB
ESAB
$5.66B
| $27.3M | 0.03% |
282,896
+132,159
| +88% | +$15.3M |
|
484
Crown Castle
CCI
$33.5B
| $27M | 0.03% |
331,564
+37,523
| +13% | +$3.23M |
|
485
VICI Properties
VICI
$29.2B
| $26.9M | 0.03% |
985,284
-1,328,352
| -57% | -$38M |
|
486
Halliburton
HAL
$26.6B
| $26.8M | 0.03% |
688,297
-509,392
| -43% | -$17.6M |
|
487
Willis Towers Watson
WTW
$31.7B
| $26.7M | 0.03% |
91,926
+8,233
| +10% | +$2.53M |
|
488
Cheniere Energy
LNG
$54.1B
| $26.7M | 0.03% |
94,150
-9,404
| -9% | -$2.17M |
|
489
Astera Labs
ALAB
$55B
| $26.7M | 0.03% |
243,543
+57,214
| +31% | +$8.15M |
|
490
Tapestry
TPR
$31.4B
| $26.6M | 0.03% |
189,021
-310,446
| -62% | -$44M |
|
491
GDS Holdings
GDS
$6.55B
| $26.3M | 0.03% |
670,491
-21,207
| -3% | -$909K |
|
492
Woodward
WWD
$21.5B
| $26.3M | 0.03% |
73,395
-21,646
| -23% | -$7.79M |
|
493
Lincoln Electric
LECO
$14.6B
| $26.1M | 0.03% |
104,724
-1,662
| -2% | -$445K |
|
494
Equinor
EQNR
$94.8B
| $25.5M | 0.03% |
604,562
+561,752
| +1,312% | +$16.9M |
|
495
Warner Bros
WBD
$65.4B
| $25.4M | 0.03% |
923,935
-87,015
| -9% | -$2.44M |
|
496
GSK
GSK
$103B
| $25.3M | 0.03% |
459,137
+202,257
| +79% | +$11M |
|
|
SNDK
497
Sandisk
SNDK
$191B
| $25.3M | 0.03% |
39,922
+34,293
| +609% | +$19.4M |
|
498
COPT Defense Properties
CDP
$4.26B
| $25.2M | 0.03% |
824,800
+1,064
| +0.1% | +$33.1K |
|
499
AerCap
AER
$24.2B
| $25.2M | 0.03% |
183,594
-54,695
| -23% | -$7.82M |
|
500
Fidelity National Information Services
FIS
$23.1B
| $25.1M | 0.03% |
534,915
+296,945
| +125% | +$16M |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.